Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
St. Jude Medical hits ‘pause’ on Portico TAVI device
Stealthy mitral valve maker emerges at TCT 2014 | MassDevice.com On Call
MASSDEVICE ON CALL — Bad timing and a financial crisis nearly buried MVRx and its mitral valve repair technology forever, but the company’s founders finally revealed their progress over the weekend at the Transcatheter Cardiovascular Therapeutics conference.
TAVI: Symetis battles the big dogs
Switzerland-based medical implant maker Symetis is looking to make some major moves in the global transcatheter aortic valve implantation market, and the company’s not afraid to take on some of the medtech industry’s biggest players.
Press Release: Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system
LAUSANNE, SWITZERLAND – Symetis SA, the leading European developer of transcatheter aortic valve implantation (TAVI) systems, announced today the launch of ACURATE neo, its 15F compatible transfemoral TAVI system. Commercial implantations started early September after Symetis received CE Mark approval for ACURATE neo this summer.
TAVI: Symetis chases Medtronic and Edwards with E.U. win for Acurate neo heart valve
Stealthy Swiss device maker Symetis announced today that it’s launching commercial sales of its Acurate neo transfemoral transcatheter aortic valve implantation system, having just won CE Mark approval from European regulators.
Medtronic wins FDA nod for NC Euphora balloon catheter
Harpoon Medical raises $3.8M for mitral valve device
Harpoon Medical is looking to move from concept to the clinic with the $3.8 million it raised in its Series A funding round in support of its mitral repair devices.
TAVI: Medtronic launches U.S. trial for CoreValve Evolut R
Tryton Medical raises $20M for side-branch stent trial
Tryton Medical said today that’s made an initial closing on a $20 million private equity round from existing and new investors.
TAVI: Claret Medical closes enrollment in brain defense study
Updated Sept. 5, 2014, at 11:00 a.m. EST.
Claret Medical announced this week that it enrolled the final patient in a European clinical trial as it chases FDA approval for its Sentinel cerebral protection device.*